Dr. Daniel Cameron

Lyme Disease Canada Debate: Bill C-442 and the Risk of Underestimation The Lyme disease Canada Bill C-442 debate highlights a critical question: is the burden of Lyme disease being underestimated? :contentReference[oaicite:0]{index=0} Although Canadian researchers acknowledge that endemic and at-risk regions for ticks expanded from 1 region in 1997 to 13 regions by 2006, some have […]

When Patients Know More Than Doctors Guest Blog By Jennifer Bybel Lown, Nurse Practitioner Dr. Daniel Cameron & Associates Lyme disease patient advocacy has become an essential part of care, especially when the illness is misunderstood or misdiagnosed. In many cases, patients and their families become the most informed voices in the diagnostic process. Patients

Borrelia miyamotoi FDA Test: Why the Diagnostic Gap Matters The FDA Testing Gap for Emerging Tick-Borne Diseases There is currently no FDA-approved test for Borrelia miyamotoi. This gap highlights a larger problem in diagnostic medicine: emerging tick-borne infections are being identified faster than regulatory pathways can support testing. :contentReference[oaicite:0]{index=0} If testing were limited only to

Lyme Disease Treatment: Why One Size Does Not Fit All Lyme disease individualized treatment is essential because patients vary widely in symptoms, response to therapy, and clinical course. A uniform approach may not address the complexity of this infection. A review of the International Lyme and Associated Diseases Society (ILADS) 2014 evidence-based guidelines highlights this

Fibromyalgia vs Lyme Disease: Could Your Diagnosis Be Wrong? Fibromyalgia vs Lyme disease is one of the most common—and important—diagnostic challenges. Both conditions share symptoms like pain, fatigue, and brain fog, making it easy to miss an underlying infection. Many patients are told they have fibromyalgia—but continue to struggle despite treatment. This raises a critical

The task force by Executive Order must submit an action plan by February 15, 2015, outlining specific steps on how to implement a national strategy to combat antibiotic resistance and accelerate research and development on new antibiotics by 2020. The task force will be led by the secretaries of Health and Human Services, the Department

Antibiotic Resistance Policy: Impact on Lyme Disease Treatment Efforts to combat antibiotic resistance are essential—but they may have unintended consequences for patients with Lyme disease. The federal task force established by Executive Order was charged with developing a national strategy to address antibiotic resistance and accelerate the development of new treatments. The task force includes

Antibiotic Resistance Policy: Impact on Lyme Disease Treatment Efforts to combat antibiotic resistance are essential—but they may have unintended consequences for patients with Lyme disease. The federal task force established by Executive Order was charged with developing a national strategy to address antibiotic resistance and accelerate the development of new treatments. The task force includes

Can You Get Lyme Disease in Ohio? Cases Are Rising Lyme disease is rising in Ohio Cases are increasing quickly Ticks are spreading across the state Risk is no longer limited Can you get Lyme disease in Ohio? Yes. Lyme disease cases in Ohio are rising, and tick populations are expanding across the state. Lyme

LLyme disease patients may struggle with depression Lyme disease depression symptoms are more common than many realize—and often misunderstood. In patients with chronic neurologic Lyme disease, depression frequently occurs alongside fatigue, headaches, cognitive difficulties, and joint pain. One study found that more than one-third of patients with chronic neurologic Lyme disease experienced depression in addition